Solovova Urethroplasty

Solovova urethroplasty is a surgical procedure that is used to treat various urethral conditions such as urethral narrowing or stricture. It was developed by the Soviet surgeon P. D. Solodov in 1875 and since then has been widely used in medicine.

Solovoplasty is an operation in which part of the patient's narrowed or compressed urethral tissue is removed and then a graft of skin or other material is installed in its place. This allows you to expand the lumen of the urethra and improve its function.

The procedure can be performed under general anesthesia or local anesthesia. After surgery, the patient usually remains in the hospital for several days to monitor his condition.

The main advantage of nightingale plastic surgery is its effectiveness and safety. However, like any other surgery, it may have some risks and complications, such as infection, bleeding, damage to the urinary tract, or other problems.

In general, nightingale plastic surgery is one of the most effective methods of treating urethral narrowing. It improves the quality of life of patients and reduces the risk of complications.

What is urethroplasty?

Urethroplasty (fallopian duct, corpus cavernosum, corpus bulbosa) is a surgical operation to restore the integrity and functionality of the urethral area after damage, trauma, or acute diseases. The term was introduced by A.P. Solodov in 1915, who in 1896 described damage to the urethra in Peyronie's disease complicated by phimosis. In 1887 E.K. Bauer bandaged the damaged urethrovaginal junction using a clamped ligature fistula according to Mikulicz (Hammacher-Zerwas-Baüer).

Damage